搜索优化
English
搜索
Copilot
图片
视频
地图
资讯
购物
更多
航班
旅游
酒店
房地产
笔记本
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
过去 24 小时
时间不限
过去 1 小时
过去 7 天
过去 30 天
按相关度排序
按时间排序
1 小时
BeiGene Advances Leadership in CLL at ASH 2024 with New Data From Its Hematology Franchise ...
At a median follow-up of 1.5 years, promising data from the 320 mg expansion cohort of phase 1/1b study shows no progression in patients with treatment-naïve CLL treated with sonrotoclax, a ...
5 小时
Fate Therapeutics Presents New Phase 1 Clinical Data of FT819 Off-the-shelf, CAR T-cell ...
All Three Patients Treated in First Dose Cohort Administered Fludarabine-free Conditioning and Show Rapid, Deep, and Sustained B-cell Depletion ...
3 小时
Odronextamab ASH Presentations Underscore Impressive Potential in Earlier Lines of ...
Odronextamab monotherapy led to complete responses in all patients with previously untreated follicular lymphoma evaluable for efficacy, per ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果
今日热点
Murder suspect charged
Not guilty in subway death
Red-flag warnings in CA
On birthright citizenship
China deploys 90 ships
Cardiovascular disease risk
Andy Kim takes office early
Exits as RNC co-chair
Quakes hit Alaska islands
Syria's chemical weapons hit
Bans cancer causing solvents
2024 word of the year
Wins Hero World Challenge
Golden Globes nominations
X removes image generator
China opens investigation
Kanlaon volcano erupts
Baseball’s HOF inductees
Ink distribution deal
Osprey flights paused again
Declines to lift gag order
Set to take witness stand
Earth drier since 1990
Swift’s Eras Tour ends
Travel ban on SK president
Women drop lawsuit
Deputy secretary of state
Seeks to pause US ban
NJ prohibits book bans
TN grabs No. 1 in AP Top 25
NJ fines sports betting firms
Judge reviews Infowars sale
反馈